SCHEMBL29601078

SCHEMBL29601078

NNc1ncnc2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATG7 O95352 1/20 0.53
▸ ADA P00813 1/20 0.51
▸ ADK P55263 6/20 0.50
▸ DOT1L Q8TEK3 2/20 0.50
▸ DCLK1 O15075 1/20 0.50
▸ DAPK3 O43293 1/20 0.50
▸ DYRK3 O43781 1/20 0.50
▸ CDK1 P06493 1/20 0.50
▸ ROS1 P08922 1/20 0.50
▸ RPS6KB1 P23443 1/20 0.50
▸ CDK2 P24941 1/20 0.50
▸ FLT3 P36888 1/20 0.50
▸ CSNK1A1 P48729 1/20 0.50
▸ CSNK1D P48730 1/20 0.50
▸ CLK2 P49760 1/20 0.50
▸ IRAK1 P51617 1/20 0.50
▸ CDK5 Q00535 1/20 0.50
▸ DYRK1A Q13627 1/20 0.50
▸ MELK Q14680 1/20 0.50
▸ NTRK3 Q16288 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30047434 0.89 ADA (0.52) ATG7ADAADKDOT1LDCLK1
SCHEMBL29600893 0.88 ADK (0.58) ATG7ADAADK
SCHEMBL4085704 0.85 ATG7 (0.69) ATG7ADAADKDOT1LDCLK1
SCHEMBL29325546 0.85 ATG7 (0.69) ATG7ADAADKDOT1LDCLK1
SCHEMBL29323418 0.85 ATG7 (0.69) ATG7ADAADKDOT1LDCLK1
SCHEMBL1737936 0.85 ATG7 (0.69) ATG7ADAADKDOT1LDCLK1
SCHEMBL29325550 0.85 ATG7 (0.69) ATG7ADAADKDOT1LDCLK1
SCHEMBL6672454 0.84 ADA (0.54) ATG7ADAADKDOT1LDCLK1
SCHEMBL11207738 0.84 ADA (0.54) ATG7ADAADKDOT1LDCLK1
SCHEMBL6671707 0.84 ADA (0.54) ATG7ADAADKDOT1LDCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450265-B Cationic lipids and uses thereof 菲克特生物科学股份有限公司 2024-12-24 — — CN claimed
WO-2025064822-A2 CELLS AND METHODS FOR ENGINEERING CELLS WITH PERSISTENT TRANSGENE EXPRESSION FACTOR BIOSCIENCE INC. (US) 2025-03-27 — — WO disclosed
WO-2024229116-A2 METHODS FOR REPROGRAMMING AND GENE EDITING CELLS FACTOR BIOSCIENCE INC. (US) 2024-11-07 — — WO disclosed
WO-2023215724-A1 METHODS FOR REPROGRAMMING AND GENE EDITING CELLS FACTOR BIOSCIENCE INC. (US) 2023-11-09 — — WO disclosed
EP-3997059-A1 CATIONIC LIPIDS AND USES THEREOF Factor Bioscience Inc. (US) 2022-05-18 — — EP disclosed
Send feedback